POLE and colorectal carcinoma: Combined, signatures linked to deamination, or defects in POLE or MMR account for the majority of mutational hotspots in the complete CRC cohort (Fig. 4c and Supplementary Table 18), and for overall mutations in the MT-H and MSS-htmb.